Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,145,046,441
-$24,376,181 QoQ
Shares Held
2,564,264
-0.6% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.84231888760283.ToString("F0")%
Shared 1.1537423603809904.ToString("F0")%
None 0.003938752016173061.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,450,444 across 417 Biotechnology names. VRTX ranks #1 (17.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,145,046,441 | 2,564,264 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,169,422,622 | 2,579,457 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,029,185,660 | 2,627,887 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,183,600,257 | 2,658,581 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,269,933,624 | 2,619,392 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,095,766,430 | 2,721,049 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,100,375,558 | 2,365,992 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $1,187,691,480 | 2,533,904 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $1,077,812,449 | 2,578,437 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,090,708,111 | 2,680,597 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $978,388,397 | 2,813,563 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $943,831,064 | 2,682,024 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $874,853,293 | 2,776,695 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $823,473,205 | 2,851,559 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $836,190,938 | 2,887,998 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $827,598,629 | 2,936,934 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $754,191,031 | 2,889,953 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $638,674,097 | 2,908,352 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $543,170,538 | 2,994,490 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $599,408,888 | 2,972,816 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $639,996,141 | 2,978,250 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $714,338,593 | 3,022,504 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $843,001,906 | 3,097,905 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $864,516,469 | 2,977,908 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $680,527,243 | 2,859,959 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||